Due to CBD’s and machaeridiols’ close structural similarities and their similar affinities for CB2, machaeridiol A–C (5–7) were examined against a panel of cancer-related signaling pathways (Table 3 and Table 4). The gene discussed is CNR2; the disease is cancer.